Catalyst Nurolight

在英国，45%的阿尔茨海默氏症患者经历过睡眠障碍，这对他们的生活质量产生了负面影响。睡眠不良会加重记忆力丧失、认知能力下降等症状，并加剧情绪激动和攻击性等行为。睡眠障碍也会对他们的护理伙伴产生负面影响，导致压力增加、抑郁和精疲力竭。当阿尔茨海默氏症患者和伴侣的睡眠都受到影响时，呆在家里就变得更具挑战性，睡眠中断被认为是阿尔茨海默氏症患者提前入院治疗的一个重要因素。研究表明，光疗法可以改善轻度阿尔茨海默氏症患者的睡眠，减少睡眠中断。在家庭环境中进行的光疗法研究也证明了光疗法对护理伙伴的好处，如延长睡眠时间和睡眠/醒来周期。我们提出了一种新技术(NuroLight)，它提供光疗法，使用现成的产品、循证研究和智能技术。这旨在提高阿尔茨海默氏症患者和他们的伴侣的生活质量，减少护理伙伴的倦怠，从而减少早期入院照顾阿尔茨海默氏症患者。随着越来越多的阿尔茨海默氏症患者生活在社区，公共支出面临压力，支持人们在家中生活得更好是当务之急。

In the UK 45% of people with Alzheimer's experience sleep disturbances which negatively impact their quality of life. Poor sleep can compound symptoms such as memory loss, cognitive decline, and exacerbate behaviours such as agitation and aggression. Sleep disturbance can also negatively impact their care partners resulting in increased stress, depression, and burnout. When the sleep of both people with Alzheimer's and partners is affected, remaining at home becomes more challenging and sleep disruption has been attributed as a significant contributing factor to people with Alzheimer's being admitted into care earlier than necessary. Research demonstrates that light therapy can improve sleep and reduce sleep disruption in mild Alzheimer's. Light therapy research undertaken in the home environment has also demonstrated benefits to care partners such as improved sleep duration and sleep/wake cycle. We propose a new technology ('NuroLight') which offers light therapy, using off-the-shelf products, evidence-based research and smart technology. This aims to improve the quality of life for both the person with Alzheimer's and their partner, reduce care partner burnout, and subsequently reduce early admittance to care for the person with Alzheimer's. With more people with Alzheimer's living in the community and public spending under pressure, supporting people to live well at home is a priority.